The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)

Sickle cell disease (SCD) is one of the commonest severe inherited disorders, but specific treatments are lacking and the pathophysiology remains unclear. Affected individuals account for well over 250,000 births yearly, mostly in the Tropics, the USA, and the Caribbean, also in N...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Hannemann, E. Weiss, D. C. Rees, S. Dalibalta, J. C. Ellory, J. S. Gibson
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Anemia
Online Access:http://dx.doi.org/10.1155/2011/248527
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555991195975680
author A. Hannemann
E. Weiss
D. C. Rees
S. Dalibalta
J. C. Ellory
J. S. Gibson
author_facet A. Hannemann
E. Weiss
D. C. Rees
S. Dalibalta
J. C. Ellory
J. S. Gibson
author_sort A. Hannemann
collection DOAJ
description Sickle cell disease (SCD) is one of the commonest severe inherited disorders, but specific treatments are lacking and the pathophysiology remains unclear. Affected individuals account for well over 250,000 births yearly, mostly in the Tropics, the USA, and the Caribbean, also in Northern Europe as well. Incidence in the UK amounts to around 12–15,000 individuals and is increasing, with approximately 300 SCD babies born each year as well as with arrival of new immigrants. About two thirds of SCD patients are homozygous HbSS individuals. Patients heterozygous for HbS and HbC (HbSC) constitute about a third of SCD cases, making this the second most common form of SCD, with approximately 80,000 births per year worldwide. Disease in these patients shows differences from that in homozygous HbSS individuals. Their red blood cells (RBCs), containing approximately equal amounts of HbS and HbC, are also likely to show differences in properties which may contribute to disease outcome. Nevertheless, little is known about the behaviour of RBCs from HbSC heterozygotes. This paper reviews what is known about SCD in HbSC individuals and will compare the properties of their RBCs with those from homozygous HbSS patients. Important areas of similarity and potential differences will be emphasised.
format Article
id doaj-art-5c561d8da01d4f5aa4aa30ce76ea6519
institution Kabale University
issn 2090-1267
2090-1275
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Anemia
spelling doaj-art-5c561d8da01d4f5aa4aa30ce76ea65192025-02-03T05:46:40ZengWileyAnemia2090-12672090-12752011-01-01201110.1155/2011/248527248527The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)A. Hannemann0E. Weiss1D. C. Rees2S. Dalibalta3J. C. Ellory4J. S. Gibson5Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UKDepartment of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UKDepartment of Molecular Haematology, King's College Hospital, London SE5 9RS, UKDepartment of Physiology, Anatomy & Genetics, University of Oxford, Parks Road, Oxford OX1 3PT, UKDepartment of Physiology, Anatomy & Genetics, University of Oxford, Parks Road, Oxford OX1 3PT, UKDepartment of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UKSickle cell disease (SCD) is one of the commonest severe inherited disorders, but specific treatments are lacking and the pathophysiology remains unclear. Affected individuals account for well over 250,000 births yearly, mostly in the Tropics, the USA, and the Caribbean, also in Northern Europe as well. Incidence in the UK amounts to around 12–15,000 individuals and is increasing, with approximately 300 SCD babies born each year as well as with arrival of new immigrants. About two thirds of SCD patients are homozygous HbSS individuals. Patients heterozygous for HbS and HbC (HbSC) constitute about a third of SCD cases, making this the second most common form of SCD, with approximately 80,000 births per year worldwide. Disease in these patients shows differences from that in homozygous HbSS individuals. Their red blood cells (RBCs), containing approximately equal amounts of HbS and HbC, are also likely to show differences in properties which may contribute to disease outcome. Nevertheless, little is known about the behaviour of RBCs from HbSC heterozygotes. This paper reviews what is known about SCD in HbSC individuals and will compare the properties of their RBCs with those from homozygous HbSS patients. Important areas of similarity and potential differences will be emphasised.http://dx.doi.org/10.1155/2011/248527
spellingShingle A. Hannemann
E. Weiss
D. C. Rees
S. Dalibalta
J. C. Ellory
J. S. Gibson
The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
Anemia
title The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
title_full The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
title_fullStr The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
title_full_unstemmed The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
title_short The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
title_sort properties of red blood cells from patients heterozygous for hbs and hbc hbsc genotype
url http://dx.doi.org/10.1155/2011/248527
work_keys_str_mv AT ahannemann thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT eweiss thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT dcrees thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT sdalibalta thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT jcellory thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT jsgibson thepropertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT ahannemann propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT eweiss propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT dcrees propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT sdalibalta propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT jcellory propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype
AT jsgibson propertiesofredbloodcellsfrompatientsheterozygousforhbsandhbchbscgenotype